Insulet Corporation
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG000R7XX87
PODD
Insulet Corporation
GICS: -
·
Sektor: Healthcare
·
Sub-Sektor: Medical Devices
NAME
Insulet Corporation
ISIN
US45784P1012
TICKER
PODD
MIC
XNAS
REUTERS
PODD.OQ
BLOOMBERG
PODD US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Do., 07.11.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended September 30, 2024.
“We continue to achieve significant milestones and robust revenue growth," said Jim Hollingshead, President and Chi...
Fr., 01.11.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to recognize National Diabetes Awareness Month and World Diabetes Day with a series of activities in November.
“People with diabetes must make dozens of decisions every day t...
Di., 29.10.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the full market release of the Omnipod 5 App for iPhone® in the U.S.
Now available to download for free on the Apple App Store, the App allows users to fully control their Omnipod ...
Mo., 30.09.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the third quarter of 2024 on November 7, 2024 after the close of the financial markets. In connection with the release, management will ho...
Mo., 26.08.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its groundbreaking Omnipod 5 Automated Insulin Delivery System (Omnipod 5) is now indicated for use by people with type 2 diabetes (ages 18 years and older) in the U.S., making it t...
Di., 20.08.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at three upcoming investor conferences (all Eastern Time):
The 2024 Wells Fargo Healthcare Conference in Boston on Wednesday, September 4, 2024 at 9:30 a.m.
The ...
Mi., 14.08.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today hosted a grand opening celebration at its new manufacturing facility in Johor Bahru, Malaysia.
This press release features multimedia. View the full release here: https://www.businesswire.co...
Do., 08.08.2024
Insulet
US45784P1012
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended June 30, 2024.
Second Quarter Financial Highlights:
Second quarter 2024 revenue of $488.5 million, up 23.2%, or 23.4% in constant c...
Informationen zu Product Placements
